(Q81424151)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15723085%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

title

Outcome of unrelated transplants in patients with multiple myeloma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15723085%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

author name string

Ballen KK

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15723085%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

King R

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15723085%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Carston M

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15723085%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Kollman C

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15723085%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Nelson G

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15723085%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Lim S

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15723085%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Reece D

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15723085%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Giralt S

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15723085%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Vesole DH

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15723085%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

publication date

1 April 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15723085%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

8 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15723085%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15723085%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15723085%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

page(s)

675-681

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15723085%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1704868

8 January 2020

exact match

0 references

cites work

Thalidomide alone or with dexamethasone for previously untreated multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704868

7 January 2021

Survival of multiple myeloma patients who are potential candidates for early high-dose therapy intensification/ autotransplantation and who were conventionally treated

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704868

7 January 2021

Combination chemotherapy versus melphalan and prednisolone in the treatment of multiple myeloma: an overview of published trials

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704868

7 January 2021

Alternating combination chemotherapy (VMCP/VBAP) is not superior to melphalan/prednisone in the treatment of multiple myeloma patients stage III--a randomized study from MGCS

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704868

7 January 2021

A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704868

7 January 2021

High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704868

7 January 2021

Survival after relapse following tandem autotransplants in multiple myeloma patients: the University of Arkansas total therapy I experience

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704868

7 January 2021

Multiple myeloma: comparison of two dose-intensive melphalan regimens (100 vs 200 mg/m(2))

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704868

7 January 2021

Single versus double autologous stem-cell transplantation for multiple myeloma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704868

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704868

1 reference

7 January 2021

High rate of remission and low rate of disease recurrence in patients with multiple myeloma allografted with PBSC from their HLA-identical sibling donors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704868

7 January 2021

Prognostic factors in allogeneic bone marrow transplantation for multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704868

7 January 2021

Outcome after autologous and allogeneic stem cell transplantation for patients with multiple myeloma: impact of graft-versus-myeloma effect

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704868

7 January 2021

Prognostic factors in allogeneic transplantation for patients with high-risk multiple myeloma after reduced intensity conditioning

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704868

7 January 2021

Fludarabine/melphalan conditioning for allogeneic transplantation in patients with multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704868

7 January 2021

Effect of HLA incompatibility on graft-versus-host disease, relapse, and survival after marrow transplantation for patients with leukemia or lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704868

7 January 2021

Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704868

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704868

7 January 2021

Estimation of failure probabilities in the presence of competing risks: new representations of old estimators

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704868

7 January 2021

Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704868

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704868

7 January 2021

Allogeneic transplantation for multiple myeloma: further evidence for a GVHD-associated graft-versus-myeloma effect

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704868

7 January 2021

Conversion to full donor chimerism following donor lymphocyte infusion is associated with disease response in patients with multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704868

7 January 2021

Chronic but not acute graft-versus-host disease improves outcome in multiple myeloma patients after non-myeloablative allogeneic transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704868

7 January 2021

Predicting long-term (> or = 5 years) event-free survival in multiple myeloma patients following planned tandem autotransplants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704868

7 January 2021

Impact of previous high-dose therapy on outcome after allografting for multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704868

7 January 2021

Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704868

7 January 2021

Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704868

7 January 2021

Improved outcome of allogeneic transplantation in high-risk multiple myeloma patients after nonmyeloablative conditioning

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704868

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704868

7 January 2021

The outcome of unrelated donor stem cell transplantation for patients with multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704868

7 January 2021

Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704868

7 January 2021

Autologous stem cell transplantation followed by a dose-reduced allograft induces high complete remission rate in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704868

7 January 2021